Depletion of CD8+ T cells in the PDX melanoma bearing NSG‐Tg(Hu‐IL15) mice did not significantly change the tumor growth rates as compared to isotype control treated HSC‐engrafted NSG‐Tg(Hu‐IL15) mice (Figure 7B). This evidence concerns the gene CD8A and melanoma.